{"id":"W2073990067","doi":"10.1038/sj.tpj.6500444","title":"Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib","year":2007,"lang":"en","type":"article","venue":"The Pharmacogenomics Journal","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"National Institute of Environmental Health Sciences; Dana-Farber/Harvard Cancer Center; National Cancer Institute; Massachusetts General Hospital; AstraZeneca","keywords":"Gefitinib; Lung cancer; Internal medicine; Epidermal growth factor receptor; Hazard ratio; Genotype; Oncology; Allele; Medicine; Biology; Gastroenterology; Tyrosine-kinase inhibitor; Rash; Confidence interval; Cancer; Genetics; Gene","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003378134,0.0002484382,0.000716101,0.000478593,0.0004707602,0.0006723554,0.0002377778,0.0008479268,0.001659239],"category_scores_gemma":[0.001796237,0.0001985589,0.0006837972,0.0007187572,0.0003051638,0.0004766444,0.0001530528,0.0007812183,0.0001682647],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004425118,"about_ca_system_score_gemma":0.0003777492,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002897158,"about_ca_topic_score_gemma":0.003387678,"domain_scores_codex":[0.9997,0.00008056396,0.00003384094,0.00006181562,0.00004644435,0.00007737896],"domain_scores_gemma":[0.9987441,0.0004387248,0.0003996664,0.00003997527,0.00007154405,0.0003059423],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.004126577,0.0001565383,0.9899484,0.00001262898,0.000305723,0.0005232325,0.00004326789,0.0002537965,0.001710402,0.00003527501,0.0002434254,0.002640586],"study_design_scores_gemma":[0.0001268777,0.0005894051,0.9965807,0.000004281355,0.000299158,0.0009197068,0.00009030079,0.0006257463,0.0004405808,0.00006448154,0.0002486271,0.00001011824],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990357,0.000332598,0.00002234483,0.00009999572,0.00001513439,0.000002234043,0.0001105018,0.000003320012,0.0003782136],"genre_scores_gemma":[0.9996208,0.00006416843,0.00001286489,0.00003237639,0.00001897979,0.000002179563,0.0001386478,0.000001229173,0.0001088349],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002897158,"threshold_uncertainty_score":0.00576055,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02554749736049241,"score_gpt":0.3590342355438876,"score_spread":0.3334867381833952,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}